Assessment of dementia

References

Key articles

Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 Feb;72(2):126-33.Full text  Abstract

Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. 2010 Feb;28(1):107-70. Abstract

Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Psychiatr Res. 2009 Jan;43(4):411-31. Abstract

Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010 Oct;17(10):1236-48.Full text  Abstract

Ross GW, Bowen JD. The diagnosis and differential diagnosis of dementia. Med Clin N Am. 2002 May;86(3):455-76. Abstract

van der Flier WM, Scheltens P. Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry. 2005 Dec;76(suppl 5):v45-52. Abstract

Prabhakar VK, Shalet SM. Aetiology, diagnosis and management of hypopituitarism in adult life. Postgrad Med J. 2006 Apr;82(966):259-66. Abstract

Reference articles

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

2. Prince M, Wimo A, Guerchet M, et al. Alzheimer's Disease International. World Alzheimer Report 2015. Aug 2015 [internet publication].Full text

3. GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Jan;18(1):88-106.Full text  Abstract

4. Alzheimer's Disease International. Dementia statistics. 2020 [internet publication].Full text

5. Goodman RA, Lochner KA, Thambisetty M, et al. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement. 2017 Jan;13(1):28-37.Full text  Abstract

6. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988 Sep 15;109(6):476-86. Abstract

7. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29.Full text  Abstract

8. Galvin JE, Sadowsky CH, NINCDS-ADRDA. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.Full text  Abstract

9. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].Full text

10. Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016 Apr;22(2 dementia):404-18.Full text  Abstract

11. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008 Jan;13(1):45-53. Abstract

12. Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 1988 Jul;38(7):1083-90. Abstract

13. Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 Jun 1;142(6):1503-1527.Full text  Abstract

14. Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer's and vascular types. Biomed Res Int. 2014;2014:908915.Full text  Abstract

15. Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology. 1995 Feb;45(2):211-8. Abstract

16. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies; report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250-60. Abstract

17. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11):1006-18. Abstract

18. Okura T, Plassman BL, Steffens DC, et al. Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011 Mar;59(3):473-81.Full text  Abstract

19. Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 Feb;72(2):126-33.Full text  Abstract

20. Jellinger KA. Head injury and dementia. Curr Opin Neurol. 2004 Dec;17(6):719-23. Abstract

21. Nordström A, Nordström P. Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study. PLoS Med. 2018 Jan 30;15(1):e1002496.Full text  Abstract

22. Barnes DE, Byers AL, Gardner RC, et al. Association of Mild Traumatic Brain Injury With and Without Loss of Consciousness With Dementia in US Military Veterans. JAMA Neurol. 2018 Sep 1;75(9):1055-1061.Full text  Abstract

23. Ropper AH. Neurosyphilis. N Engl J Med. 2019 Oct 3;381(14):1358-1363.Full text  Abstract

24. Spero M, Lazibat I. Creutzfeldt-Jakob disease: case report and review of the literature. Acta Clin Croat. 2010 Jun;49(2):181-7. Abstract

25. Fox C, Smith T, Maidment I, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014 Sep;43(5):604-15.Full text  Abstract

26. Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018 Apr 25;361:k1315.Full text  Abstract

27. Coupland CAC, Hill T, Dening T, et al. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019 Jun 24;:.Full text  Abstract

28. Jayadevappa R, Chhatre S, Malkowicz SB, et al. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer. JAMA Netw Open. 2019 Jul 3;2(7):e196562.Full text  Abstract

29. Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):362-7. Abstract

30. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management. Mar 2019 [internet publication].Full text

31. Hokkanen L, Launes J. Neuropsychological sequelae of acute-onset sporadic viral encephalitis. Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):450-77. Abstract

32. Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. 2010 Feb;28(1):107-70. Abstract

33. Attupurath R, Menon RC, Nair SV, et al. Late-life depression. Ann Long Term Care Clin Care Aging. 2008;16(suppl):21-9.Full text

34. Kongpakwattana K, Sawangjit R, Tawankanjanachot I, et al. Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis. Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456.Full text  Abstract

35. Ralph SJ, Espinet AJ. Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. J Alzheimers Dis Rep. 2018 Feb 2;2(1):1-26.Full text  Abstract

36. Reus VI, Fochtmann LJ, Eyler AE, et al. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry. 2016 May 1;173(5):543-6.Full text  Abstract

37. Yunusa I, Alsumali A, Garba AE, et al. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis. JAMA Netw Open. 2019 Mar 1;2(3):e190828.Full text  Abstract

38. APA Work Group on Alzheimer's Disease and other Dementias, Rabins PV, Blacker D, Rovner BW, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias, second edition. Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56. Abstract

39. Fleming KC, Adams AC, Petersen RC. Dementia: diagnosis and evaluation. Mayo Clin Proc. 1995 Nov;70(11):1093-107. Abstract

40. Rodakowski J, Skidmore ER, Reynolds CF 3rd, et al. Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc. 2014 Jul;62(7):1347-52.Full text  Abstract

41. Abell JG, Kivimäki M, Dugravot A, et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018 Sep 1;39(33):3119-3125.Full text  Abstract

42. Koch M, Fitzpatrick AL, Rapp SR, et al. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment. JAMA Netw Open. 2019 Sep 4;2(9):e1910319.Full text  Abstract

43. Klingelhofer LR. Delirium, psychosis and dementia in patients with Parkinson's disease. Aktuelle Neurologie. 2011;38:303-08.

44. Petersen RC, Mokri B, Laws ER Jr. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology. 1985 Mar;35(3):307-11. Abstract

45. Graff-Radford NR, Godersky JC, Jones MP. Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly. Neurology. 1989 Dec;39(12):1601-4. Abstract

46. Mulrow CD, Feussner JR, Williams BC, et al. The value of clinical findings in the detection of normal pressure hydrocephalus. J Gerontol. 1987 May;42(3):277-9. Abstract

47. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med. 1991 Jul 15;115(2):122-32. Abstract

48. U.S. Preventive Services Task Force. Cognitive impairment in older adults: screening. Feb 2020 [internet publication].Full text

49. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. Abstract

50. Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8. Abstract

51. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Psychiatr Res. 2009 Jan;43(4):411-31. Abstract

52. Peters R, Pinto EM. Predictive value of the Clock Drawing Test. A review of the literature. Dement Geriatr Cogn Disord. 2008;26(4):351-5. Abstract

53. Castilla-Rilo J, López-Arrieta J, Bermejo-Pareja F, et al. Instrumental activities of daily living in the screening of dementia in population studies: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2007 Sep;22(9):829-36. Abstract

54. Holsinger T, Deveau J, Boustani M, et al. Does this patient have dementia? JAMA. 2007 Jun 6;297(21):2391-404. Abstract

55. Wolfs CA, Dirksen CD, Kessels A, et al. Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry. 2009 Mar;66(3):313-23. Abstract

56. Jongstra S, van Gool WA, Moll van Charante EP, et al. Improving prediction of dementia in primary care. Ann Fam Med. 2018 May;16(3):206-10.Full text  Abstract

57. Appels BA, Scherder E. The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review. Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):301-16. Abstract

58. Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Cochrane Database Syst Rev. 2018;(2):CD011415.Full text  Abstract

59. Chan CC, Fage BA, Burton JK, et al. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting. Cochrane Database Syst Rev. 2019 Sep 14;9:CD011414.Full text  Abstract

60. Brodaty H, Connors MH, Loy C, et al. Screening for Dementia in Primary Care: A Comparison of the GPCOG and the MMSE. Dement Geriatr Cogn Disord. 2016;42(5-6):323-330.Full text  Abstract

61. Teng E, Becker BW, Woo E, et al. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):348-53.Full text  Abstract

62. Merello M, Sabe L, Teson A, et al. Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1503-9.Full text  Abstract

63. Huff FJ, Belle SH, Shim YK, et al. Prevalence and prognostic value of neurologic abnormalities in Alzheimer's disease. Dementia. 1990;1:32-40.

64. Gates GA, Karzon RK, Garcia P, et al. Auditory dysfunction in aging and senile dementia of the Alzheimer's type. Arch Neurol. 1995 Jun;52(6):626-34. Abstract

65. Oppenheim G. The earliest signs of Alzheimer's disease. J Geriatr Psychiatry Neurol. 1994 Apr-Jun;7(2):116-20. Abstract

66. Cummings JL, Miller B, Hill MA, et al. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol. 1987 Apr;44(4):389-93. Abstract

67. Tampi RR, van Dyck CH, et al. Behavioral and psychological symptoms of Alzheimer's disease. In: Sun MK (ed). Research progress in Alzheimer's disease and dementia (Vol 2). Hauppauge, NY: Blanchette Rockefeller Neurosciences Institute, Nova Publishers; 2006:251-72.

68. Mathias JL, Morphett K. Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: a meta-analysis. J Clin Exp Neuropsychol. 2010 Aug;32(7):682-98. Abstract

69. Silva MT, Laks J, Engelhardt E. Neuropsychological tests and driving in dementia: a review of the recent literature. Rev Assoc Med Bras. 2009 Jul-Aug;55(4):484-8. Abstract

70. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older American normative studies. Clin Neuropsychol. 1992;6(Suppl):83-104.

71. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch Intern Med. 1986 Oct;146(10):1917-22. Abstract

72. Centers for Disease Control and Prevention. 2015 STD Treatment Guidelines: Syphilis. Jun 2015 [internet publication].Full text

73. Wippold FJ 2nd, Brown DC, Broderick DF, et al. ACR appropriateness criteria dementia and movement disorders. J Am Coll Radiol. 2015 Jan;12(1):19-28.Full text  Abstract

74. Scheltens P, Fox N, Barkhof F, et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1:13-21. Abstract

75. Dormont D, Seidenwurm DJ; Expert Panel on Neurologic Imaging; American College of Radiology. Dementia and movement disorders. AJNR Am J Neuroradiol. 2008 Jan;29(1):204-6.Full text  Abstract

76. Yuan Y, Gu ZX, Wei WS. Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol. 2009 Feb;30(2):404-10.Full text  Abstract

77. Jagust WJ. Amyloid imaging: coming to a PET scanner near you. Ann Neurol. 2010 Sep;68(3):277-8. Abstract

78. Tarnaris A, Kitchen ND, Watkins LD. Noninvasive biomarkers in normal pressure hydrocephalus: evidence for the role of neuroimaging. J Neurosurg. 2009 May;110(5):837-51. Abstract

79. Pennington C, Chohan G, Mackenzie J, et al. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neurosci Lett. 2009 May 8;455(1):56-9. Abstract

80. Mitchell AJ, Meader N, Pentzek M. Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy. Acta Psychiatr Scand. 2011 Sep;124(3):165-83. Abstract

81. Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010 Oct;17(10):1236-48.Full text  Abstract

82. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011 Jun;13(6):597-605.Full text  Abstract

83. Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012 Jan;123(1):1-11.Full text  Abstract

84. Feldman HH, Jacova C, Mild cognitive impairment, Am J Geriatr Psychiatry. 2005 Aug;13(8):645-55. Abstract

85. Ross GW, Bowen JD. The diagnosis and differential diagnosis of dementia. Med Clin N Am. 2002 May;86(3):455-76. Abstract

86. Cummings JL. Amnesia, paramnesia, and confabulation. Clinical neuropsychiatry. Orlando, FL: Grune and Stratton; 1985;36-47.

87. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-5. Abstract

88. Kopelman MD. Disorders of memory. Brain. 2002 Oct;125(Pt 10):2152-90.Full text  Abstract

89. Benson DF. Aphasia, alexia, and agraphia. New York, NY: Churchill Livingstone; 1979.

90. Ross GW, Cummings JL, Benson DF. Speech and language alterations in dementia syndromes: characteristics and treatment. Aphasiology. 1990;4:339-52.

91. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun study. Neurology. 2002 May 28;58(10):1476-82. Abstract

92. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997 Sep;49(3):786-94. Abstract

93. van der Flier WM, Scheltens P. Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry. 2005 Dec;76(suppl 5):v45-52. Abstract

94. Meyer MA, Hudock SA. Posterior cortical atrophy: A rare variant of Alzheimer's disease. Neurol Int. 2018 May 24;10(2):7665.Full text  Abstract

95. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 4;89(1):88-100.Full text  Abstract

96. Liyanagedera S, Bracewell RM, Larner AJ. Diagnosing dementia with Lewy bodies: new diagnostic criteria. J R Coll Physicians Edinb. 2018 Mar;48(1):44-45.Full text  Abstract

97. Lindau M, Almkvist O, Kushi J, et al. First symptoms - frontotemporal dementia versus Alzheimer's disease. Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):286-93. Abstract

98. Clarke CE. Parkinson's disease. BMJ. 2007 Sep 1;335(7617):441-5. Abstract

99. Montoya A, Price BH, Menear M, et al. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci. 2006 Jan;31(1):21-9.Full text  Abstract

100. DeAngelis LM. Brain tumors. N Engl J Med. 2001 Jan 11;344(2):114-23. Abstract

101. Orth DN. Cushing's syndrome [published correction appears in N Engl J Med. 1995;332:1527]. N Engl J Med. 1995 Mar 23;332(12):791-803. Abstract

102. Prabhakar VK, Shalet SM. Aetiology, diagnosis and management of hypopituitarism in adult life. Postgrad Med J. 2006 Apr;82(966):259-66. Abstract

103. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist. 2007 Jun;12(6):644-53.Full text  Abstract

104. Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ. 2000 Jun 17;320(7250):1647-51.Full text  Abstract

105. Ryder SD, Beckingham IJ. ABC of diseases of liver pancreas and biliary system. Other causes of parenchymal liver disease. BMJ. 2001 Feb 3;322(7281):290-2.Full text  Abstract

106. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003 Jun;37(6):1475-92.Full text  Abstract

107. French P. Syphilis. BMJ. 2007 Jan 20;334(7585):143-7. Abstract

108. Spach DH, Liles WC, Campbell GL, et al. Tick-borne diseases in the United States. N Engl J Med. 1993 Sep 23;329(13):936-47. Abstract

109. Mead P, Petersen J, Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text  Abstract

110. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Full text

111. World Health Organization. WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection. Jun 2020 [internet publication].Full text

112. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15;64(2):111-115.Full text  Abstract

113. Thwaite GE. The diagnosis and management of tuberculous meningitis. Pract Neurol. 2002;2:250-61.

114. Carsons S. A review and update of Sjogren's syndrome: manifestations, diagnosis and treatment. Am J Manag Care. 2001 Sep;7(14 Suppl):S433-43. Abstract

115. Brennan MT, Sankar V, Leakan RA, at al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum. 2002 Apr 15;47(2):189-95. Abstract

116. Newman LS, Rose CS, Maier LA. Sarcoidosis [published correction appears in N Engl J Med. 1997;337:139]. N Engl J Med. 1997 Apr 24;336(17):1224-34. Abstract

117. Verrees M, Selman WR. Management of normal pressure hydrocephalus. Am Fam Physician. 2004 Sep 15;70(6):1071-8.Full text  Abstract

Use of this content is subject to our disclaimer